Company / Operating Income
Moderna Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$3.1B
FY2025
5-year range
-$4.2B / -$546.0M
FY2021-FY2025
Trend
+22.1%
vs FY2024
Sector context
#204 of 204
Health Care
What the data says
Among 204 Health Care companies, Moderna is in the bottom 0% for operating income. Operating Income has fluctuated over the past 10 years, ranging from -$4.2B in FY2023 to -$224M in FY2016.
Based on SEC 10-K filings.
-$3.1B in FY2025.
Improved from -$4.2B to -$3.1B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 204This company -$3.1B Sector average $107.7M
▼
-2953.7% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 22.1% year-over-year.
- Ranks #204 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2016.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.1B | +22.1% |
| FY2024 | -$3.9B | +6.9% |
| FY2023 | -$4.2B | -455.6% |
| FY2022 | -$763.0M | -39.7% |
| FY2021 | -$546.0M | +28.4% |
| FY2020 | -$763.0M | -39.7% |
| FY2019 | -$546.0M | -32.1% |
| FY2018 | -$413.3M | -53.4% |
| FY2017 | -$269.4M | -20.4% |
| FY2016 | -$223.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026